AnthonyHunterMD

Hematology • Atlanta, GA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Assistant Professor, Emory University School of Medicine, Winship Cancer Institute

Join to view full profile

Dr. Hunter is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hunter's full profile

Already have an account?

Office
1365 Clifton Road
Winship Cancer Institute
Atlanta, GA 30322
Phone(608) 692-4151
Is this information wrong?

Education & Training

University of South Florida Morsani College of MedicineFellowship, Hematology/Oncology, 2017 - 2020
Emory UniversityResidency, Internal Medicine, 2014 - 2017
Medical College of WisconsinClass of 2014

Certifications & Licensure

GA State Medical License 2020 - 2021
FL State Medical License 2017 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Molecular genetics of MDS/MPN overlap syndromes.
Hunter, A. M., Padron, E.> ;Best practice & research. Clinical haematology. 2020 Oct 12

Abstracts/Posters

Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
Anthony Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Patient Derived Xenografts (PDX) Recapitulate Ruxolitinib Clinical Trial Responses and Identify a Novel Combination Therapy for Chronic Myelomonocytic Leukemia (CMML)
Anthony M. Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study ...
Anthony M. Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Bone Marrow Mastocytosis Is Independently Associated with Inferior Survival in Chronic Myelomonocytic Leukemia
Anthony Hunter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

CSF3R Mutations Are Exceedingly Rare Genetic Events Associated with Inferior Survival and Sensitivity to Ruxolitinib across Myeloid Malignancies
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
WHO-Defined Chronic Myelomonocytic Leukemia-2 (CMML-2) Patients Rapidly Progress to AML Suggesting This Entity Represents a Transitory Clinical State
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

A Legacy of TyrosineMay 11th, 2020